MANUEL
PRAGA TERENTE
Profesor emérito
University of Washington
Seattle, Estados UnidosUniversity of Washington-ko ikertzaileekin lankidetzan egindako argitalpenak (3)
2023
-
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
The Lancet, Vol. 402, Núm. 10417, pp. 2077-2090
-
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
The Lancet, Vol. 401, Núm. 10388, pp. 1584-1594
2017
-
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis
Kidney International Reports, Vol. 2, Núm. 5, pp. 800-810